Myeloid cells activate iNKT cells to produce IL-4 in the thymic medulla
- 14 October 2019
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (44) , 22262-22268
Abstract
Interleukin-4 (IL-4) is produced by a unique subset of invariant natural killer T (iNKT) cells (NKT2) in the thymus in the steady state, where it conditions CD8+ T cells to become “memory-like” among other effects. However, the signals that cause NKT2 cells to constitutively produce IL-4 remain poorly defined. Using histocytometry, we observed IL-4–producing NKT2 cells localized to the thymic medulla, suggesting that medullary signals might instruct NKT2 cells to produce IL-4. Moreover, NKT2 cells receive and require T cell receptor (TCR) stimulation for continuous IL-4 production in the steady state, since NKT2 cells lost IL-4 production when intrathymically transferred into CD1d-deficient recipients. In bone marrow chimeric recipients, only hematopoietic, not stromal, antigen-presenting cells (APCs), provided such stimulation. Furthermore, using different Cre-recombinase transgenic mouse strains to specifically target CD1d deficiency to various APCs, together with the use of diphtheria toxin receptor (DTR) transgenic mouse strains to deplete various APCs, we found that macrophages were the predominant cell to stimulate NKT2 IL-4 production. Thus, NKT2 cells appear to encounter and require different activating ligands for selection in the cortex and activation in the medulla. Significance T cells, essential components of the immune system, are developed in the thymus. Various effector cytokines are produced in the thymus in the steady state, which affect T cell development and tolerance. Interleukin-4 (IL-4) produced by a unique subset of lipid-specific invariant natural killer T (iNKT) cells (NKT2) in the steady state influences a series of immune events to alter thymic development. However, the underling mechanisms for this steady-state IL-4 production are not completely understood. In this study, we show that steady-state IL-4–producing NKT2 cells predominantly localize to the thymic medulla. Furthermore, this steady-state IL-4 production requires continuous T cell receptor (TCR) signaling in NKT2 cells majorly stimulated by thymic macrophages.Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI39560)
- Division of Intramural Research (F30 AI131483)
- Division of Intramural Research (T32 AI007313)
- HHS | NIH | National Institute of General Medical Sciences (T32 GM008244)
- University of Minnesota (DDF)
This publication has 54 references indexed in Scilit:
- Distinct APCs Explain the Cytokine Bias of α-Galactosylceramide Variants In VivoThe Journal of Immunology, 2012
- T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouseJournal of Experimental Medicine, 2011
- KLF13 sustains thymic memory-like CD8+ T cells in BALB/c mice by regulating IL-4–generating invariant natural killer T cellsJournal of Experimental Medicine, 2011
- T cells expressing the transcription factor PLZF regulate the development of memory-like CD8+ T cellsNature Immunology, 2010
- KLF2 Transcription-Factor Deficiency in T Cells Results in Unrestrained Cytokine Production and Upregulation of Bystander Chemokine ReceptorsImmunity, 2009
- A Two-Step Process for Cytokine Production Revealed by IL-4 Dual-Reporter MiceImmunity, 2005
- Genetic Evidence Supporting Selection of the Vα14i NKT Cell Lineage from Double-Positive Thymocyte PrecursorsImmunity, 2005
- In Vivo Activation of Antigen-Specific CD4 T CellsAnnual Review of Immunology, 2001
- Heterogeneity of Mouse Thymic Macrophages: I. Immunohistochemical Analysis.Archives of Histology and Cytology, 1997
- Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes.Journal of Experimental Medicine, 1995